Implementation planning for lung cancer screening: five major challenges

The Lancet Respiratory Medicine

Volumn 4, Issue 9, 2016, Pages 685-687

  Field, John K ^a   Duffy, Stephen W ^b   Devaraj, Anand ^c   Baldwin, David R ^d  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^d NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HEALTH PROGRAM; HUMAN; ISCHEMIC HEART DISEASE; LUNG CANCER; MEASUREMENT ACCURACY; MEASUREMENT PRECISION; NOTE; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION; SOCIAL STATUS; EARLY CANCER DIAGNOSIS; LUNG TUMOR; MASS SCREENING; X-RAY COMPUTED TOMOGRAPHY;

EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; MASS SCREENING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84989870081     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(16)30233-8     Document Type: Note

References (12)

1. 1 National Lung Screening Trial Research Team, Aberle, DR, Adams, AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365 (2011), 395–409.
2. 2 van der Aalst, CM, ten Haaf, K, de Koning, HJ, Lung cancer screening: latest developments and unanswered questions. Lancet Respir Med 4 (2016), 749–761.
3. 3 Clinical Practice Guidelines in Oncology: Lung Cancer Screening V.2 2016. https://www.nccn.org/professionals/physician_gls/pdf/lung_screening.pdf (accessed Aug 5, 2016).
4. 4 Field, JK, Duffy, SW, Baldwin, DR, et al. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. Health Technol Assess 20 (2016), 1–146.
5. 5 Tammemagi, MC, Katki, HA, Hocking, WG, et al. Selection criteria for lung-cancer screening. N Engl J Med 368 (2013), 728–736.
6. 6 Bryan, L, Westmaas, L, Alcaraz, K, Jemal, A, Cigarette smoking and cancer screening underutilization by state: BRFSS 2010. Nicotine Tob Res 16 (2014), 1183–1189.
7. 7 Murray, RL, Bauld, L, Hackshaw, LE, McNeill, A, Improving access to smoking cessation services for disadvantaged groups: a systematic review. J Public Health (Oxf) 31 (2009), 258–277.
8. 8 Sutton, S, Wardle, J, Taylor, T, et al. Predictors of attendance in the United Kingdom flexible sigmoidoscopy screening trial. J Med Screen 7 (2000), 99–104.
9. 9 Nair, A, Baldwin, DR, Field, JK, Hansell, DM, Devaraj, A, Measurement methods and algorithms for the management of solid nodules. J Thorac Imaging 27 (2012), 230–239.
10. 10 Horeweg, N, van Rosmalen, J, Heuvelmans, MA, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 15 (2014), 1332–1341.
11. 11 Baldwin, DR, Callister, ME, Guideline Development, G, The British Thoracic Society guidelines on the investigation and management of pulmonary nodules. Thorax 70 (2015), 794–798.
12. 12 Field, JK, Perspective: the screening imperative. Nature, 513, 2014, S7.